{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T02:13:35Z","timestamp":1791598415501,"version":"4.3.4"},"reference-count":96,"publisher":"Walter de Gruyter GmbH","issue":"1","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,5,14]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Multiple sclerosis (MS) is a chronic immune-mediated disease of the central nervous system characterized by neuroinflammation and progressive neurodegeneration. Growing evidence suggests that dietary interventions may influence MS progression and symptom management by modulating inflammation, oxidative stress, and gut microbiota composition. This narrative review examines the effects of the Mediterranean, plant-based, ketogenic, Wahls, Swank, intermittent fasting, and gluten-free diets, alongside key nutrients such as omega-3 fatty acids, vitamin D, polyphenols, and antioxidants. Among these, Mediterranean and plant-based diets have shown the most consistent benefits, including reductions in fatigue, improved quality of life, and modulation of inflammatory markers. The Wahls and Swank diets show promise but are primarily supported by studies from their respective research groups, raising concerns about long-term adherence and nutritional adequacy. The ketogenic diet and intermittent fasting have yielded mixed findings, with some studies suggesting benefits for fatigue and neuroprotection, while others highlight potential metabolic risks. The gluten-free diet and omega-3 supplementation lack robust evidence, with inconsistent findings across studies. Additionally, ultra-processed foods and diets high in saturated fats have been associated with increased inflammation and greater MS severity. Despite promising findings, limitations such as small sample sizes, short follow-up durations, and study design inconsistencies prevent definitive conclusions. Future research should prioritize large-scale, long-term randomized controlled trials to establish the efficacy, safety, and sustainability of dietary interventions in MS management. Mechanistic studies and standardized dietary protocols are also needed to better understand the role of diet in MS progression and symptom control.<\/jats:p>","DOI":"10.1515\/tnsci-2025-0371","type":"journal-article","created":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T11:42:17Z","timestamp":1747222937000},"source":"Crossref","is-referenced-by-count":10,"title":["From prevention to management: Exploring the impact of diet on multiple sclerosis"],"prefix":"10.1515","volume":"16","author":[{"given":"Dalya","family":"Koukach","sequence":"first","affiliation":[{"name":"Department of Nutrition Sciences, College of Health Science, Qatar University , Doha , 2713 , Qatar"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Aljumaily","sequence":"additional","affiliation":[{"name":"Department of Nutrition Sciences, College of Health Science, Qatar University , Doha , 2713 , Qatar"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noora","family":"Al-Attiyah","sequence":"additional","affiliation":[{"name":"Department of Nutrition Sciences, College of Health Science, Qatar University , Doha , 2713 , Qatar"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rawdhah","family":"Al-Amer","sequence":"additional","affiliation":[{"name":"Department of Nutrition Sciences, College of Health Science, Qatar University , Doha , 2713 , Qatar"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasmine","family":"Attia","sequence":"additional","affiliation":[{"name":"Department of Nutrition Sciences, College of Health Science, Qatar University , Doha , 2713 , Qatar"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1640-0511","authenticated-orcid":false,"given":"Reema","family":"Tayyem","sequence":"additional","affiliation":[{"name":"Department of Nutrition Sciences, College of Health Science, Qatar University , Doha , 2713 , Qatar"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"374","published-online":{"date-parts":[[2025,5,14]]},"reference":[{"key":"2025122010110642134_j_tnsci-2025-0371_ref_001","unstructured":"Tafti D, Ehsan M, Xixis KL. Multiple sclerosis. [Updated 2024 Mar 20]. In StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK499849\/."},{"key":"2025122010110642134_j_tnsci-2025-0371_ref_002","doi-asserted-by":"crossref","unstructured":"Powell B, Mills R, Tennant A, Young CA, Langdon D. Stigma and health outcomes in multiple sclerosis: A systematic review. BMC Neurol. 2024;24(1):346.","DOI":"10.1186\/s12883-024-03853-3"},{"key":"2025122010110642134_j_tnsci-2025-0371_ref_003","doi-asserted-by":"crossref","unstructured":"Deleu D, Mir D, Al Tabouki A, Mesraoua R, Mesraoua B, Akhtar N, et al. Prevalence, demographics and clinical characteristics of multiple sclerosis in Qatar. Mult Scler. 2013;19(6):816\u20139.","DOI":"10.1177\/1352458512459291"},{"key":"2025122010110642134_j_tnsci-2025-0371_ref_004","doi-asserted-by":"crossref","unstructured":"Bagur MJ, Murcia MA, Jim\u00e9nez-Monreal AM, Tur JA, Bibiloni MM, Alonso GL, et al. Influence of diet in multiple sclerosis: A systematic review. Adv Nutr. 2017;8(3):463\u201372.","DOI":"10.3945\/an.116.014191"},{"key":"2025122010110642134_j_tnsci-2025-0371_ref_005","doi-asserted-by":"crossref","unstructured":"Thompson AJ, Baranzini SE, Geurts J, Hemmer B, Ciccarelli O. Multiple sclerosis. Lancet. 2018 Oct;392(10147):1622\u201336.","DOI":"10.1016\/S0140-6736(18)30481-1"},{"key":"2025122010110642134_j_tnsci-2025-0371_ref_006","doi-asserted-by":"crossref","unstructured":"Hauser SL, Cree BAC. Treatment of multiple sclerosis: A review. Am J Med. 2020;133(12):1380\u201390.e2.","DOI":"10.1016\/j.amjmed.2020.05.049"},{"key":"2025122010110642134_j_tnsci-2025-0371_ref_007","doi-asserted-by":"crossref","unstructured":"Oliveira de Andrade Filho V, Amarante MOC, Gonzalez-Lima F, Gomes da Silva S, Cardoso FDS. Systematic review of photobiomodulation for multiple sclerosis. Front Neurol. 2024;15:1465621.","DOI":"10.3389\/fneur.2024.1465621"},{"key":"2025122010110642134_j_tnsci-2025-0371_ref_008","doi-asserted-by":"crossref","unstructured":"Tredinnick AR, Probst YC. Evaluating the effects of dietary interventions on disease progression and symptoms of adults with multiple sclerosis: An umbrella review. Adv Nutr. 2020;11(6):1603\u201315.","DOI":"10.1093\/advances\/nmaa063"},{"key":"2025122010110642134_j_tnsci-2025-0371_ref_009","doi-asserted-by":"crossref","unstructured":"Harirchian MH, Karimi E, Bitarafan S. Diet and disease-related outcomes in multiple sclerosis: A systematic review of clinical trials. Curr J Neurol. 2022;21(1):52\u201363.","DOI":"10.18502\/cjn.v21i1.9362"},{"key":"2025122010110642134_j_tnsci-2025-0371_ref_010","doi-asserted-by":"crossref","unstructured":"Mandato C, Colucci A, Lanzillo R, Staiano A, Scarpato E, Schiavo L, et al. Multiple sclerosis-related dietary and nutritional issues: An updated scoping review with a focus on pediatrics. Children (Basel). 2023;10(6):1022.","DOI":"10.3390\/children10061022"},{"key":"2025122010110642134_j_tnsci-2025-0371_ref_011","doi-asserted-by":"crossref","unstructured":"Hoare S, Lithander F, van der Mei I, Ponsonby AL, Lucas R. Higher intake of omega-3 polyunsaturated fatty acids is associated with a decreased risk of a first clinical diagnosis of central nervous system demyelination: Results from the Ausimmune Study. Mult Scler. 2016;22(7):884\u201392.","DOI":"10.1177\/1352458515604380"},{"key":"2025122010110642134_j_tnsci-2025-0371_ref_012","doi-asserted-by":"crossref","unstructured":"Hoover DB. Cholinergic modulation of the immune system presents new approaches for treating inflammation. Pharmacol Ther. 2017;179:1\u201316.","DOI":"10.1016\/j.pharmthera.2017.05.002"},{"key":"2025122010110642134_j_tnsci-2025-0371_ref_013","doi-asserted-by":"crossref","unstructured":"Riccio P, Rossano R. Diet, gut microbiota, and vitamins D + A in multiple sclerosis. Neurotherapeutics. 2018;15(1):75\u201391.","DOI":"10.1007\/s13311-017-0581-4"},{"key":"2025122010110642134_j_tnsci-2025-0371_ref_014","doi-asserted-by":"crossref","unstructured":"Riccio P, Rossano R. Nutrition facts in multiple sclerosis. ASN Neuro. 2015;7(1):1759091414568185.","DOI":"10.1177\/1759091414568185"},{"key":"2025122010110642134_j_tnsci-2025-0371_ref_015","doi-asserted-by":"crossref","unstructured":"De la Fuente M. Effects of antioxidants on immune system ageing. Eur J Clin Nutr. 2002;56(Suppl 3):S5\u20138.","DOI":"10.1038\/sj.ejcn.1601476"},{"key":"2025122010110642134_j_tnsci-2025-0371_ref_016","doi-asserted-by":"crossref","unstructured":"Miller E, Markiewicz L, Kabzinski J, Odrobina D, Majsterek I. Potential of redox therapies in neurodegenerative disorders. Front Biosci (Elite Ed). 2017;9(2):214\u201334.","DOI":"10.2741\/e797"},{"key":"2025122010110642134_j_tnsci-2025-0371_ref_017","doi-asserted-by":"crossref","unstructured":"Skovgaard L, Tr\u00e9nel P, Westergaard K, Knudsen AK. Dietary patterns and their associations with symptom levels among people with multiple sclerosis: A real-world digital study. Neurol Ther. 2023;12(4):1335\u201357.","DOI":"10.1007\/s40120-023-00505-5"},{"key":"2025122010110642134_j_tnsci-2025-0371_ref_018","doi-asserted-by":"crossref","unstructured":"Razeghi-Jahromi S, Doosti R, Ghorbani Z, Saeedi R, Abolhasani M, Akbari N, et al. A randomized controlled trial investigating the effects of a mediterranean-like diet in patients with multiple sclerosis-associated cognitive impairments and fatigue. Curr J Neurol. 2020;19(3):112\u201321.","DOI":"10.18502\/cjn.v19i3.5424"},{"key":"2025122010110642134_j_tnsci-2025-0371_ref_019","doi-asserted-by":"crossref","unstructured":"Giesser BS, Rapozo M, Glatt R, Patis C, Panos S, Merrill DA, et al. Lifestyle intervention improves cognition and quality of life in persons with early multiple sclerosis. Mult Scler Relat Disord. 2024;91:105897.","DOI":"10.1016\/j.msard.2024.105897"},{"key":"2025122010110642134_j_tnsci-2025-0371_ref_020","doi-asserted-by":"crossref","unstructured":"Razeghi-Jahromi S, Doosti R, Ghorbani Z, Saeedi R, Abolhasani M, Akbari N, et al. A randomized controlled trial investigating the effects of a Mediterranean-like diet in patients with multiple sclerosis-associated cognitive impairments and fatigue. Curr J Neurol. 2020;19(3):112\u201321.","DOI":"10.18502\/cjn.v19i3.5424"},{"key":"2025122010110642134_j_tnsci-2025-0371_ref_021","doi-asserted-by":"crossref","unstructured":"Snetselaar LG, Cheek JJ, Fox SS, Healy HS, Schweizer ML, Bao W, et al. Efficacy of diet on fatigue and quality of life in multiple sclerosis: A systematic review and network meta-analysis of randomized trials. Neurology. 2023;100(4):e357\u201366.","DOI":"10.1212\/WNL.0000000000201371"},{"key":"2025122010110642134_j_tnsci-2025-0371_ref_022","doi-asserted-by":"crossref","unstructured":"Mirza AI, Zhu F, Knox N, Black LJ, Daly A, Bonner C, et al. Mediterranean diet and associations with the gut microbiota and pediatric-onset multiple sclerosis using trivariate analysis. Commun Med (Lond). 2024;4(1):148.","DOI":"10.1038\/s43856-024-00565-0"},{"key":"2025122010110642134_j_tnsci-2025-0371_ref_023","doi-asserted-by":"crossref","unstructured":"Mohan M, Okeoma CM, Sestak K. Dietary gluten and neurodegeneration: A case for preclinical studies. Int J Mol Sci. 2020;21(15):5407.","DOI":"10.3390\/ijms21155407"},{"key":"2025122010110642134_j_tnsci-2025-0371_ref_024","doi-asserted-by":"crossref","unstructured":"Thirion F, Sellebjerg F, Fan Y, Lyu L, Hansen TH, Pons N, et al. The gut microbiota in multiple sclerosis varies with disease activity. Genome Med. 2023;15(1):1.","DOI":"10.1186\/s13073-022-01148-1"},{"key":"2025122010110642134_j_tnsci-2025-0371_ref_025","doi-asserted-by":"crossref","unstructured":"Yadav V, Marracci G, Kim E, Spain R, Cameron M, Overs S, et al. Low-fat, plant-based diet in multiple sclerosis: A randomized controlled trial. Mult Scler Relat Disord. 2016;9:80\u201390.","DOI":"10.1016\/j.msard.2016.07.001"},{"key":"2025122010110642134_j_tnsci-2025-0371_ref_026","doi-asserted-by":"crossref","unstructured":"Walters SJ, Brazier JE. Comparison of the minimally important difference for two health state utility measures: EQ-5D and SF-6D. Qual Life Res. 2005;14(6):1523\u201332.","DOI":"10.1007\/s11136-004-7713-0"},{"key":"2025122010110642134_j_tnsci-2025-0371_ref_027","doi-asserted-by":"crossref","unstructured":"Ogura K, Yakoub MA, Christ AB, Fujiwara T, Nikolic Z, Boland PJ, et al. What are the minimum clinically important differences in SF-36 scores in patients with orthopaedic oncologic conditions? Clin Orthop Relat Res. 2020;478(9):2148\u201358.","DOI":"10.1097\/CORR.0000000000001341"},{"key":"2025122010110642134_j_tnsci-2025-0371_ref_028","doi-asserted-by":"crossref","unstructured":"Hadgkiss EJ, Jelinek GA, Weiland TJ, Pereira NG, Marck CH, van der Meer DM. The association of diet with quality of life, disability, and relapse rate in an international sample of people with multiple sclerosis. Nutr Neurosci. 2015;18(3):125\u201336.","DOI":"10.1179\/1476830514Y.0000000117"},{"key":"2025122010110642134_j_tnsci-2025-0371_ref_029","doi-asserted-by":"crossref","unstructured":"Yu M, Neate S, Nag N, Bevens W, Jelinek G, Simpson-Yap S, et al. Baseline engagement with healthy lifestyles and their associations with health outcomes in people with multiple sclerosis enrolled in an online multimodal lifestyle course. Eur J Neurol. 2024;31(10):e16429.","DOI":"10.1111\/ene.16429"},{"key":"2025122010110642134_j_tnsci-2025-0371_ref_030","doi-asserted-by":"crossref","unstructured":"Yu M, Jelinek G, Simpson-Yap S, Neate S, Nag N. Self-reported ongoing adherence to diet is associated with lower depression, fatigue, and disability, in people with multiple sclerosis. Front Nutr. 2023;10:979380.","DOI":"10.3389\/fnut.2023.979380"},{"key":"2025122010110642134_j_tnsci-2025-0371_ref_031","doi-asserted-by":"crossref","unstructured":"Wahls TL, Titcomb TJ, Bisht B, Eyck PT, Rubenstein LM, Carr LJ, et al. Impact of the Swank and Wahls elimination dietary interventions on fatigue and quality of life in relapsing-remitting multiple sclerosis: The WAVES randomized parallel-arm clinical trial. Mult Scler J Exp Transl Clin. 2021;7(3):20552173211035399.","DOI":"10.1177\/20552173211035399"},{"key":"2025122010110642134_j_tnsci-2025-0371_ref_032","unstructured":"Titcomb TJ, Brooks L, Smith KL, Ten Eyck P, Rubenstein LM, Wahls TL, et al. Association between improved serum fatty acid profiles and cognitive function during a dietary intervention trial in relapsing-remitting multiple sclerosis. Nutr Neurosci. 2023;26(10):741\u201351."},{"key":"2025122010110642134_j_tnsci-2025-0371_ref_033","doi-asserted-by":"crossref","unstructured":"Titcomb TJ, Brooks L, Smith KL, Ten Eyck P, Rubenstein LM, Wahls TL, et al. Change in micronutrient intake among people with relapsing-remitting multiple sclerosis adapting the Swank and Wahls diets: An analysis of weighed food records. Nutrients. 2021;13(10):3507.","DOI":"10.3390\/nu13103507"},{"key":"2025122010110642134_j_tnsci-2025-0371_ref_034","doi-asserted-by":"crossref","unstructured":"Irish AK, Erickson CM, Wahls TL, Snetselaar LG, Darling WG. Randomized control trial evaluation of a modified Paleolithic dietary intervention in the treatment of relapsing-remitting multiple sclerosis: A pilot study. Degener Neurol Neuromuscul Dis. 2017;7:1\u201318.","DOI":"10.2147\/DNND.S116949"},{"key":"2025122010110642134_j_tnsci-2025-0371_ref_035","doi-asserted-by":"crossref","unstructured":"Bisht B, Darling WG, Grossmann RE, Shivapour ET, Lutgendorf SK, Snetselaar LG, et al. A multimodal intervention for patients with secondary progressive multiple sclerosis: Feasibility and effect on fatigue. J Altern Complement Med. 2014;20(5):347\u201355.","DOI":"10.1089\/acm.2013.0188"},{"key":"2025122010110642134_j_tnsci-2025-0371_ref_036","doi-asserted-by":"crossref","unstructured":"Bisht B, Darling WG, Shivapour ET, Lutgendorf SK, Snetselaar LG, Chenard CA, et al. Multimodal intervention improves fatigue and quality of life in subjects with progressive multiple sclerosis: A pilot study. Degener Neurol Neuromuscul Dis. 2015;5:19\u201335.","DOI":"10.2147\/DNND.S76523"},{"key":"2025122010110642134_j_tnsci-2025-0371_ref_037","doi-asserted-by":"crossref","unstructured":"Atabilen B, Akdevelio\u011flu Y. Effects of different dietary interventions in multiple sclerosis: A systematic review of evidence from 2018 to 2022. Nutr Neurosci. 2023;26(12):1279\u201391.","DOI":"10.1080\/1028415X.2022.2146843"},{"key":"2025122010110642134_j_tnsci-2025-0371_ref_038","doi-asserted-by":"crossref","unstructured":"Dy\u0144ka D, Kowalcze K, Paziewska A. The role of ketogenic diet in the treatment of neurological diseases. Nutrients. 2022;14(23):5003.","DOI":"10.3390\/nu14235003"},{"key":"2025122010110642134_j_tnsci-2025-0371_ref_039","doi-asserted-by":"crossref","unstructured":"Koh S, Dupuis N, Auvin S. Ketogenic diet and neuroinflammation. Epilepsy Res. 2020;167:106454.","DOI":"10.1016\/j.eplepsyres.2020.106454"},{"key":"2025122010110642134_j_tnsci-2025-0371_ref_040","doi-asserted-by":"crossref","unstructured":"Di Majo D, Cacciabaudo F, Accardi G, Gambino G, Giglia G, Ferraro G, et al. Ketogenic and modified mediterranean diet as a tool to counteract neuroinflammation in multiple sclerosis: Nutritional suggestions. Nutrients. 2022;14(12):2384.","DOI":"10.3390\/nu14122384"},{"key":"2025122010110642134_j_tnsci-2025-0371_ref_041","doi-asserted-by":"crossref","unstructured":"Brenton JN, Lehner-Gulotta D, Woolbright E, Banwell B, Bergqvist AGC, Chen S, et al. Phase II study of ketogenic diets in relapsing multiple sclerosis: Safety, tolerability and potential clinical benefits. J Neurol Neurosurg Psychiatry. 2022;93(6):637\u201344.","DOI":"10.1136\/jnnp-2022-329074"},{"key":"2025122010110642134_j_tnsci-2025-0371_ref_042","doi-asserted-by":"crossref","unstructured":"Ort\u00ed JER, Cuerda-Ballester M, Sanchis-Sanchis CE, Lajara Romance JM, Navarro-Illana E, Garc\u00eda Pardo MP. Exploring the impact of ketogenic diet on multiple sclerosis: Obesity, anxiety, depression, and the glutamate system. Front Nutr. 2023;10:1227431.","DOI":"10.3389\/fnut.2023.1227431"},{"key":"2025122010110642134_j_tnsci-2025-0371_ref_043","doi-asserted-by":"crossref","unstructured":"de Cabo R, Mattson MP. Effects of intermittent fasting on health, aging, and disease. N Engl J Med. 2019;381(26):2541\u201351.","DOI":"10.1056\/NEJMra1905136"},{"key":"2025122010110642134_j_tnsci-2025-0371_ref_044","doi-asserted-by":"crossref","unstructured":"Jamshed H, Steger FL, Bryan DR, Richman JS, Warriner AH, Hanick CJ, et al. Effectiveness of early time-restricted eating for weight loss, fat loss, and cardiometabolic health in adults with obesity: A randomized clinical trial. JAMA Intern Med. 2022;182(9):953\u201362.","DOI":"10.1001\/jamainternmed.2022.3050"},{"key":"2025122010110642134_j_tnsci-2025-0371_ref_045","doi-asserted-by":"crossref","unstructured":"Li Z, Heber D. Intermittent fasting. JAMA. 2021;326(13):1338.","DOI":"10.1001\/jama.2020.15140"},{"key":"2025122010110642134_j_tnsci-2025-0371_ref_046","unstructured":"Razeghi Jahromi S, Ghaemi A, Alizadeh A, Sabetghadam F, Moradi Tabriz H, Togha M. Effects of intermittent fasting on experimental autoimune encephalomyelitis in C57BL\/6 mice. Iran J Allergy Asthma Immunol. 2016;15(3):212\u20139."},{"key":"2025122010110642134_j_tnsci-2025-0371_ref_047","doi-asserted-by":"crossref","unstructured":"Fitzgerald KC, Bhargava P, Smith MD, Vizthum D, Henry-Barron B, Kornberg MD, et al. Intermittent calorie restriction alters T cell subsets and metabolic markers in people with multiple sclerosis. EBioMedicine. 2022;82:104124.","DOI":"10.1016\/j.ebiom.2022.104124"},{"key":"2025122010110642134_j_tnsci-2025-0371_ref_048","doi-asserted-by":"crossref","unstructured":"Sonnenburg JL, B\u00e4ckhed F. Diet-microbiota interactions as moderators of human metabolism. Nature. 2016;535(7610):56\u201364.","DOI":"10.1038\/nature18846"},{"key":"2025122010110642134_j_tnsci-2025-0371_ref_049","doi-asserted-by":"crossref","unstructured":"Le Chatelier E, Nielsen T, Qin J, Prifti E, Hildebrand F, Falony G, et al. Richness of human gut microbiome correlates with metabolic markers. Nature. 2013;500(7464):541\u20136.","DOI":"10.1038\/nature12506"},{"key":"2025122010110642134_j_tnsci-2025-0371_ref_050","doi-asserted-by":"crossref","unstructured":"Fitzgerald KC, Vizthum D, Henry-Barron B, Schweitzer A, Cassard SD, Kossoff E, et al. Effect of intermittent vs daily calorie restriction on changes in weight and patient-reported outcomes in people with multiple sclerosis. Mult Scler Relat Disord. 2018;23:33\u20139.","DOI":"10.1016\/j.msard.2018.05.002"},{"key":"2025122010110642134_j_tnsci-2025-0371_ref_051","doi-asserted-by":"crossref","unstructured":"Cignarella F, Cantoni C, Ghezzi L, Salter A, Dorsett Y, Chen L, et al. Intermittent fasting confers protection in CNS autoimmunity by altering the gut microbiota. Cell Metab. 2018;27(6):1222\u201335.e6.","DOI":"10.1016\/j.cmet.2018.05.006"},{"key":"2025122010110642134_j_tnsci-2025-0371_ref_052","doi-asserted-by":"crossref","unstructured":"Zieli\u0144ska M, Micho\u0144ska I. Effectiveness of various diet patterns among patients with multiple sclerosis. Postep Psychiatr Neurol. 2023;32(1):49\u201358.","DOI":"10.5114\/ppn.2023.127246"},{"key":"2025122010110642134_j_tnsci-2025-0371_ref_053","doi-asserted-by":"crossref","unstructured":"Temperley IA, Seldon AN, Reckord MA, Yarad CA, Islam FT, Duncanson K, et al. Dairy and gluten in disease activity in multiple sclerosis. Mult Scler J Exp Transl Clin. 2023;9(4):20552173231218107.","DOI":"10.1177\/20552173231218107"},{"key":"2025122010110642134_j_tnsci-2025-0371_ref_054","doi-asserted-by":"crossref","unstructured":"Zevallos VF, Yogev N, Hauptmann J, Nikolaev A, Pickert G, Heib V, et al. Dietary wheat amylase trypsin inhibitors exacerbate CNS inflammation in experimental multiple sclerosis. Gut. 2023;73(1):92\u2013104.","DOI":"10.1136\/gutjnl-2023-329562"},{"key":"2025122010110642134_j_tnsci-2025-0371_ref_055","doi-asserted-by":"crossref","unstructured":"Mannino A, Daly A, Dunlop E, Probst Y, Ponsonby AL, van der Mei IAF, et al. Higher consumption of ultra-processed foods and increased likelihood of central nervous system demyelination in a case-control study of Australian adults. Eur J Clin Nutr. 2023;77(5):611\u20134.","DOI":"10.1038\/s41430-023-01271-1"},{"key":"2025122010110642134_j_tnsci-2025-0371_ref_056","doi-asserted-by":"crossref","unstructured":"Guglielmetti M, Grosso G, Ferraris C, Bergamaschi R, Tavazzi E, La Malfa A, et al. Ultra-processed foods consumption is associated with multiple sclerosis severity. Front Neurol. 2023;14:1086720.","DOI":"10.3389\/fneur.2023.1086720"},{"key":"2025122010110642134_j_tnsci-2025-0371_ref_057","doi-asserted-by":"crossref","unstructured":"Kleinewietfeld M, Manzel A, Titze J, Kvakan H, Yosef N, Linker RA, et al. Sodium chloride drives autoimmune disease by the induction of pathogenic TH17 cells. Nature. 2013;496(7446):518\u201322.","DOI":"10.1038\/nature11868"},{"key":"2025122010110642134_j_tnsci-2025-0371_ref_058","doi-asserted-by":"crossref","unstructured":"Miclea A, Bagnoud M, Chan A, Hoepner R. A brief review of the effects of vitamin D on multiple sclerosis. Front Immunol. 2020;11:781.","DOI":"10.3389\/fimmu.2020.00781"},{"key":"2025122010110642134_j_tnsci-2025-0371_ref_059","doi-asserted-by":"crossref","unstructured":"Ghaseminejad-Raeini A, Ghaderi A, Sharafi A, Nematollahi-Sani B, Moossavi M, Derakhshani A, et al. Immunomodulatory actions of vitamin D in various immune-related disorders: A comprehensive review. Front Immunol. 2023;14:950465.","DOI":"10.3389\/fimmu.2023.950465"},{"key":"2025122010110642134_j_tnsci-2025-0371_ref_060","doi-asserted-by":"crossref","unstructured":"Balasooriya NN, Elliott TM, Neale RE, Vasquez P, Comans T, Gordon LG. The association between vitamin D deficiency and multiple sclerosis: An updated systematic review and meta-analysis. Mult Scler Relat Disord. 2024;90:105804.","DOI":"10.1016\/j.msard.2024.105804"},{"key":"2025122010110642134_j_tnsci-2025-0371_ref_061","doi-asserted-by":"crossref","unstructured":"Bitarafan S, Zhu F, Mirza A, Bernstein CN, Van Domselaar G, Marrie RA, et al. Assessment of dietary intake and its inflammatory potential in persons with pediatric-onset multiple sclerosis. Mult Scler Relat Disord. 2024;86:105599.","DOI":"10.1016\/j.msard.2024.105599"},{"key":"2025122010110642134_j_tnsci-2025-0371_ref_062","doi-asserted-by":"crossref","unstructured":"Abbasi H, Khoshdooz S, Alem E, Bakhshimoghaddam F, Doaei S, Goodarzi MO. Vitamin D in multiple sclerosis: A comprehensive umbrella review. J Nutr. 2024;154(12):3505\u201320.","DOI":"10.1016\/j.tjnut.2024.10.004"},{"key":"2025122010110642134_j_tnsci-2025-0371_ref_063","doi-asserted-by":"crossref","unstructured":"Runia TF, Hop WC, de Rijke YB, Buljevac D, Hintzen RQ. Lower serum vitamin D levels are associated with a higher relapse risk in multiple sclerosis. Neurology. 2012;79(3):261\u20136.","DOI":"10.1212\/WNL.0b013e31825fdec7"},{"key":"2025122010110642134_j_tnsci-2025-0371_ref_064","doi-asserted-by":"crossref","unstructured":"Wang C, Zeng Z, Wang B, Guo S. Lower 25-hydroxyvitamin D is associated with higher relapse risk in patients with relapsing-remitting multiple sclerosis. J Nutr Health Aging. 2018;22(1):38\u201343.","DOI":"10.1007\/s12603-017-0894-3"},{"key":"2025122010110642134_j_tnsci-2025-0371_ref_065","doi-asserted-by":"crossref","unstructured":"Mahler JV, Solti M, Ap\u00f3stolos-Pereira SL, Adoni T, Silva GD, Callegaro D. Vitamin D3 as an add-on treatment for multiple sclerosis: A systematic review and meta-analysis of randomized controlled trials. Mult Scler Relat Disord. 2024;82:105433.","DOI":"10.1016\/j.msard.2024.105433"},{"key":"2025122010110642134_j_tnsci-2025-0371_ref_066","doi-asserted-by":"crossref","unstructured":"James E, Dobson R, Kuhle J, Baker D, Giovannoni G, Ramagopalan SV. The effect of vitamin D-related interventions on multiple sclerosis relapses: A meta-analysis. Mult Scler. 2013;19(12):1571\u20139.","DOI":"10.1177\/1352458513489756"},{"key":"2025122010110642134_j_tnsci-2025-0371_ref_067","doi-asserted-by":"crossref","unstructured":"Mehrabadi S, Zahedi E. Effects of vitamin D supplementation on inflammatory markers in multiple sclerosis patients: A systematic review and meta-analysis. J Arch Mil Med. 2023;9(1):e112426.","DOI":"10.5812\/jamm.112426"},{"key":"2025122010110642134_j_tnsci-2025-0371_ref_068","doi-asserted-by":"crossref","unstructured":"Kousparou C, Fyrilla M, Stephanou A, Patrikios I. DHA\/EPA (Omega-3) and LA\/GLA (Omega-6) as bioactive molecules in neurodegenerative diseases. Int J Mol Sci. 2023;24(13):10717.","DOI":"10.3390\/ijms241310717"},{"key":"2025122010110642134_j_tnsci-2025-0371_ref_069","doi-asserted-by":"crossref","unstructured":"AlAmmar WA, Albeesh FH, Ibrahim LM, Algindan YY, Yamani LZ, Khattab RY. Effect of omega-3 fatty acids and fish oil supplementation on multiple sclerosis: A systematic review. Nutr Neurosci. 2021;24(7):569\u201379.","DOI":"10.1080\/1028415X.2019.1659560"},{"key":"2025122010110642134_j_tnsci-2025-0371_ref_070","doi-asserted-by":"crossref","unstructured":"Beckett JM, Bird ML, Pittaway JK, Ahuja KD. Diet and multiple sclerosis: Scoping review of web-based recommendations. Interact J Med Res. 2019;8(1):e10050.","DOI":"10.2196\/10050"},{"key":"2025122010110642134_j_tnsci-2025-0371_ref_071","doi-asserted-by":"crossref","unstructured":"Birnbaum G, Stulc J. High dose biotin as treatment for progressive multiple sclerosis. Mult Scler Relat Disord. 2017;18:141\u20133.","DOI":"10.1016\/j.msard.2017.09.030"},{"key":"2025122010110642134_j_tnsci-2025-0371_ref_072","doi-asserted-by":"crossref","unstructured":"Torkildsen O, Wergeland S, Bakke S, Beiske AG, Bjerve KS, Hovdal H, et al. \u03c9-3 fatty acid treatment in multiple sclerosis (OFAMS Study): A randomized, double-blind, placebo-controlled trial. Arch Neurol. 2012;69(8):1044\u201351.","DOI":"10.1001\/archneurol.2012.283"},{"key":"2025122010110642134_j_tnsci-2025-0371_ref_073","unstructured":"Mauriz E, Laliena A, Vallejo D, Tu\u00f1\u00f3n MJ, Rodr\u00edguez-L\u00f3pez JM, Rodr\u00edguez-P\u00e9rez R, et al. Effects of a low-fat diet with antioxidant supplementation on biochemical markers of multiple sclerosis long-term care residents. Nutr Hosp. 2013;28(6):2229\u201335."},{"key":"2025122010110642134_j_tnsci-2025-0371_ref_074","doi-asserted-by":"crossref","unstructured":"Moravejolahkami AR, Chitsaz A, Hassanzadeh A, Paknahad Z. Anti-inflammatory-antioxidant modifications and synbiotics improved health-related conditions in patients with progressive forms of multiple sclerosis: A single-center, randomized clinical trial. Complement Ther Clin Pract. 2023;53:101794.","DOI":"10.1016\/j.ctcp.2023.101794"},{"key":"2025122010110642134_j_tnsci-2025-0371_ref_075","doi-asserted-by":"crossref","unstructured":"Moravejolahkami AR, Chitsaz A, Hassanzadeh A, Paknahad Z. Effects of anti-inflammatory-antioxidant-rich diet and co-supplemented synbiotics intervention in patients with progressive forms of multiple sclerosis: A single-center, single-blind randomized clinical trial. Nutr Neurosci. 2023;26(11):1078\u201389.","DOI":"10.1080\/1028415X.2022.2128010"},{"key":"2025122010110642134_j_tnsci-2025-0371_ref_076","doi-asserted-by":"crossref","unstructured":"Guan JZ, Guan WP, Maeda T. Vitamin E administration erases an enhanced oxidation in multiple sclerosis. Can J Physiol Pharmacol. 2018;96(11):1181\u20133.","DOI":"10.1139\/cjpp-2018-0246"},{"key":"2025122010110642134_j_tnsci-2025-0371_ref_077","doi-asserted-by":"crossref","unstructured":"Rudrapal M, Khairnar SJ, Khan J, Dukhyil AB, Ansari MA, Alomary MN, et al. Dietary polyphenols and their role in oxidative stress-induced human diseases: Insights into protective effects, antioxidant potentials and mechanism(s) of action. Front Pharmacol. 2022;13:806470.","DOI":"10.3389\/fphar.2022.806470"},{"key":"2025122010110642134_j_tnsci-2025-0371_ref_078","doi-asserted-by":"crossref","unstructured":"Dolati S, Ahmadi M, Aghebti-Maleki L, Nikmaram A, Marofi F, Rikhtegar R, et al. Nanocurcumin is a potential novel therapy for multiple sclerosis by influencing inflammatory mediators. Pharmacol Rep. 2018;70(6):1158\u201367.","DOI":"10.1016\/j.pharep.2018.05.008"},{"key":"2025122010110642134_j_tnsci-2025-0371_ref_079","doi-asserted-by":"crossref","unstructured":"Dolati S, Babaloo Z, Ayromlou H, Ahmadi M, Rikhtegar R, Rostamzadeh D, et al. Nanocurcumin improves regulatory T-cell frequency and function in patients with multiple sclerosis. J Neuroimmunol. 2019;327:15\u201321.","DOI":"10.1016\/j.jneuroim.2019.01.007"},{"key":"2025122010110642134_j_tnsci-2025-0371_ref_080","doi-asserted-by":"crossref","unstructured":"Petracca M, Quarantelli M, Moccia M, Vacca G, Satelliti B, D\u2019Ambrosio G, et al. Prospective study to evaluate efficacy, safety and tolerability of dietary supplement of curcumin (BCM95) in subjects with active relapsing multiple sclerosis treated with subcutaneous interferon beta 1a 44 mcg TIW (CONTAIN): A randomized, controlled trial. Mult Scler Relat Disord. 2021;56:103274.","DOI":"10.1016\/j.msard.2021.103274"},{"key":"2025122010110642134_j_tnsci-2025-0371_ref_081","doi-asserted-by":"crossref","unstructured":"Means JC, Lopez AA, Koulen P. Resveratrol protects optic nerve head astrocytes from oxidative stress-induced cell death by preventing caspase-3 activation, tau dephosphorylation at ser(422) and formation of misfolded protein aggregates. Cell Mol Neurobiol. 2020;40(6):911\u201326.","DOI":"10.1007\/s10571-019-00781-6"},{"key":"2025122010110642134_j_tnsci-2025-0371_ref_082","doi-asserted-by":"crossref","unstructured":"Villar-Delfino PH, Santos RP, Christo PP, Nogueira-Machado JA, Volpe CMO. Antioxidant effects of resveratrol in granulocytes from multiple sclerosis patients. Explor Neurosci. 2024;3:362\u201374.","DOI":"10.37349\/en.2024.00055"},{"key":"2025122010110642134_j_tnsci-2025-0371_ref_083","doi-asserted-by":"crossref","unstructured":"Koushki M, Dashatan NA, Meshkani R. Effect of resveratrol supplementation on inflammatory markers: A systematic review and meta-analysis of randomized controlled trials. Clin Ther. 2018;40(7):1180\u201392.e5.","DOI":"10.1016\/j.clinthera.2018.05.015"},{"key":"2025122010110642134_j_tnsci-2025-0371_ref_084","unstructured":"Hossen I, Kaiqi Z, Hua W, Junsong X, Mingquan H, Yanping C. Role of polyphenols in the management of neurodegenerative diseases: Alzheimer\u2019s and Parkinson\u2019s. Nutrients. 2022;14(3):620."},{"key":"2025122010110642134_j_tnsci-2025-0371_ref_085","doi-asserted-by":"crossref","unstructured":"Rust R, Chien C, Scheel M, Brandt AU, D\u00f6rr J, Wuerfel J, et al. Epigallocatechin gallate in progressive MS: A randomized, placebo-controlled trial. Neurol Neuroimmunol Neuroinflamm. 2021;8(3):e964.","DOI":"10.1212\/NXI.0000000000000964"},{"key":"2025122010110642134_j_tnsci-2025-0371_ref_086","doi-asserted-by":"crossref","unstructured":"Sedel F, Papeix C, Bellanger A, Touitou V, Lebrun-Frenay C, Galanaud D, et al. High doses of biotin in chronic progressive multiple sclerosis: A pilot study. Mult Scler Relat Disord. 2015;4(2):159\u201369.","DOI":"10.1016\/j.msard.2015.01.005"},{"key":"2025122010110642134_j_tnsci-2025-0371_ref_087","doi-asserted-by":"crossref","unstructured":"Tourbah A, Lebrun-Frenay C, Edan G, Clanet M, Papeix C, Vukusic S, et al. MD1003 (high-dose biotin) for the treatment of progressive multiple sclerosis: A randomised, double-blind, placebo-controlled study. Mult Scler. 2016;22(13):1719\u201331.","DOI":"10.1177\/1352458516667568"},{"key":"2025122010110642134_j_tnsci-2025-0371_ref_088","doi-asserted-by":"crossref","unstructured":"Couloume L, Barbin L, Leray E, Wiertlewski S, Le Page E, Kerbrat A, et al. High-dose biotin in progressive multiple sclerosis: A prospective study of 178 patients in routine clinical practice. Mult Scler. 2020;26(14):1898\u2013906.","DOI":"10.1177\/1352458519894713"},{"key":"2025122010110642134_j_tnsci-2025-0371_ref_089","doi-asserted-by":"crossref","unstructured":"Miyake S, Kim S, Suda W, Oshima K, Nakamura M, Matsuoka T, et al. Dysbiosis in the gut microbiota of patients with multiple sclerosis, with a striking depletion of species belonging to clostridia XIVa and IV clusters. PLoS One. 2015;10(9):e0137429.","DOI":"10.1371\/journal.pone.0137429"},{"key":"2025122010110642134_j_tnsci-2025-0371_ref_090","doi-asserted-by":"crossref","unstructured":"Stoiloudis P, Kesidou E, Bakirtzis C, Sintila SA, Konstantinidou N, Boziki M, et al. The role of diet and interventions on multiple sclerosis: A review. Nutrients. 2022;14(6):1150.","DOI":"10.3390\/nu14061150"},{"key":"2025122010110642134_j_tnsci-2025-0371_ref_091","doi-asserted-by":"crossref","unstructured":"Berer K, Gerdes LA, Cekanaviciute E, Jia X, Xiao L, Xia Z, et al. Gut microbiota from multiple sclerosis patients enables spontaneous autoimmune encephalomyelitis in mice. Proc Natl Acad Sci U S A. 2017;114(40):10719\u201324.","DOI":"10.1073\/pnas.1711233114"},{"key":"2025122010110642134_j_tnsci-2025-0371_ref_092","doi-asserted-by":"crossref","unstructured":"Tremlett H, Fadrosh DW, Faruqi AA, Zhu F, Hart J, Roalstad S, et al. US network of pediatric MS centers. Gut microbiota in early pediatric multiple sclerosis: A case-control study. Eur J Neurol. 2016;23(8):1308\u201321.","DOI":"10.1111\/ene.13026"},{"key":"2025122010110642134_j_tnsci-2025-0371_ref_093","doi-asserted-by":"crossref","unstructured":"Moles L, Otaegui D. The impact of diet on microbiota evolution and human health. Is diet an adequate tool for microbiota modulation? Nutrients. 2020;12(6):1654.","DOI":"10.3390\/nu12061654"},{"key":"2025122010110642134_j_tnsci-2025-0371_ref_094","doi-asserted-by":"crossref","unstructured":"Lombardi VC, De Meirleir KL, Subramanian K, Nourani SM, Dagda RK, Delaney SL, et al. Nutritional modulation of the intestinal microbiota; future opportunities for the prevention and treatment of neuroimmune and neuroinflammatory disease. J Nutr Biochem. 2018;61:1\u201316.","DOI":"10.1016\/j.jnutbio.2018.04.004"},{"key":"2025122010110642134_j_tnsci-2025-0371_ref_095","doi-asserted-by":"crossref","unstructured":"Kouchaki E, Tamtaji OR, Salami M, Bahmani F, Daneshvar Kakhaki R, Akbari E, et al. Clinical and metabolic response to probiotic supplementation in patients with multiple sclerosis: A randomized, double-blind, placebo-controlled trial. Clin Nutr. 2017;36(5):1245\u20139.","DOI":"10.1016\/j.clnu.2016.08.015"},{"key":"2025122010110642134_j_tnsci-2025-0371_ref_096","doi-asserted-by":"crossref","unstructured":"Mahler JV, Solti M, Ap\u00f3stolos-Pereira SL, Adoni T, Silva GD, Callegaro D. Vitamin D(3) as an add-on treatment for multiple sclerosis: A systematic review and meta-analysis of randomized controlled trials. Mult Scler Relat Disord. 2024;82:105433.","DOI":"10.1016\/j.msard.2024.105433"}],"container-title":["Translational Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/tnsci-2025-0371\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/tnsci-2025-0371\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,20]],"date-time":"2025-12-20T10:14:22Z","timestamp":1766225662000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/tnsci-2025-0371\/html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,1]]},"references-count":96,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,4,24]]},"published-print":{"date-parts":[[2025,4,24]]}},"alternative-id":["10.1515\/tnsci-2025-0371"],"URL":"https:\/\/doi.org\/10.1515\/tnsci-2025-0371","relation":{},"ISSN":["2081-6936"],"issn-type":[{"value":"2081-6936","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,1]]},"article-number":"20250371"}}